Guggenheim Capital’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-32,038
| Closed | -$1.03M | – | 1877 |
|
|
2024
Q2 | $1.03M | Buy |
32,038
+17,525
| +121% | +$564K | 0.01% | 1099 |
|
|
2024
Q1 | $563K | Buy |
+14,513
| New | +$563K | ﹤0.01% | 1427 |
|
|
2022
Q3 | – | Sell |
-39,309
| Closed | -$697K | – | 1932 |
|
|
2022
Q2 | $697K | Buy |
39,309
+2,116
| +6% | +$37.5K | 0.01% | 1405 |
|
|
2022
Q1 | $757K | Sell |
37,193
-465
| -1% | -$9.46K | ﹤0.01% | 1496 |
|
|
2021
Q4 | $703K | Sell |
37,658
-4,068
| -10% | -$75.9K | ﹤0.01% | 1516 |
|
|
2021
Q3 | $823K | Sell |
41,726
-7,797
| -16% | -$154K | ﹤0.01% | 1518 |
|
|
2021
Q2 | $1.17M | Sell |
49,523
-1,926
| -4% | -$45.5K | 0.01% | 1400 |
|
|
2021
Q1 | $1.22M | Buy |
51,449
+19,879
| +63% | +$471K | 0.01% | 1293 |
|
|
2020
Q4 | $632K | Buy |
31,570
+11,392
| +56% | +$228K | ﹤0.01% | 1536 |
|
|
2020
Q3 | $420K | Buy |
+20,178
| New | +$420K | ﹤0.01% | 1503 |
|